The bill, which passed the House overwhelmingly in September, would halt federal contracts for companies partnering with named Chinese biotech companies. Wenstrup and other supporters warn that ...

Halozyme Therapeutics, a San Diego-based biopharmaceutical company, has made a $2.1 billion bid to buy German drugmaker ...

Venture capital firms incubate, grow and finance dozens of new drug companies each year. Follow the money they channel into ...

Halozyme Therapeutics has withdrawn its $2.1 billion offer to buy Evotec after the German company “has been unwilling to engage with us to explore a potential combination,” Halozyme president and CEO ...

Biotech, bitcoin, and gold ETFs may be among the best bets for investors next year thanks to the effects of the Federal ...

Eli Lilly and Hong Kong-listed Laekna will collaborate to develop an experimental obesity drug that aims to help patients ...

We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, we are going to take a look ...

One of these bacteria is particularly neat – it literally eats up the stuff that makes your muscles burn during exercise.

Biotech Vertex Pharmaceuticals (VRTX) has been struggling on the charts over the past few weeks, putting a dent in its now 10 ...

Novartis had one eye on the struggles its peers have encountered in the muscular dystrophy space when it decided to acquire ...

Own stocks of companies that get drugs approved. That hasn’t been so easy. But the U.S. Food & Drug Administration (FDA) has ...